Combined nelfinavir and cisplatin treatment promotes inflammatory signaling and immunogenic cell death in ovarian cancer cells

Platinum (Pt) based chemotherapy remains central to ovarian cancer (OC) treatment, but recurrent disease frequently develops Pt resistance and responds poorly to immune checkpoint inhibitors. Immunogenic cell death (ICD) links tumor cell killing to antitumor immunity; however, cisplatin (CDDP), widely used in OC, is an incomplete ICD inducer. We previously demonstrated that the HIV protease inhibitor nelfinavir (NFV) enhances CDDP induced OC cell death and promotes a lytic, pyroptosis associated phenotype. Here, we investigated whether NFV enhances the immunogenic consequences of CDDP treatment. RNA seq analysis of OC cells treated with CDDP, NFV, or their combination revealed enrichment of interferon (IFN) associated, cytoplasmic DNA sensing, inflammatory chemokine, and antigen presentation pathways following NFV containing treatments. NFV alone and CDDP plus NFV reduced mature Lamin A abundance and increased extranuclear double stranded DNA accumulation. Cytosolic fractionation and droplet digital PCR demonstrated increased cytosolic TP53 DNA, particularly following combined treatment. CDDP plus NFV increased STING and TBK1 phosphorylation, supporting engagement of the cGAS STING TBK1 signaling pathway. The combination enhanced release of inflammatory and ICD associated mediators, including HMGB1, IL18, and IFNbeta. Importantly, vaccination with CDDP plus NFV-treated murine ID8 OC cells protected immunocompetent female mice against subsequent live ID8 cell challenge, reducing tumor incidence and burden. In contrast, ID8 cells killed by freeze thaw-induced accidental necrosis provided no comparable protection. Collectively, these findings indicate that NFV enhances the immunogenic consequences of CDDP induced OC cell death, potentially involving cytoplasmic DNA accumulation and STING TBK1 signaling, and promotes protective antitumor immunity in vivo. These results support further investigation of NFV as a repurposed partner for Pt based chemotherapy and its potential combination with immunotherapy in OC.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-18
DOI
https://doi.org/10.64898/2026.11.16.767109
Primary Topic
Ovarian cancer diagnosis and treatment
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Combined nelfinavir and cisplatin treatment promotes inflammatory signaling and immunogenic cell death in ovarian cancer cells

Edith Zorychta, Alicia Alejandra Goyeneche, Sarah Tadhg Ferrier, Carlos Marcelo Telleria et al.
2 links
bioRxiv (Cold Spring Harbor Laboratory)
Ovarian cancer diagnosis and treatment
preprint

Combined nelfinavir and cisplatin treatment promotes inflammatory signaling and immunogenic cell death in ovarian cancer cells

Edith Zorychta, Alicia Alejandra Goyeneche, Sarah Tadhg Ferrier, Carlos Marcelo Telleria, Benjamin N. Forgie, Julia Valdemarin Burnier, Alexandra Bartolomucci, Lucy Gilbert, Rewati Prakash, Abu SM Noman, Desiree Marmo
preprint en

Abstract

Platinum (Pt) based chemotherapy remains central to ovarian cancer (OC) treatment, but recurrent disease frequently develops Pt resistance and responds poorly to immune checkpoint inhibitors. Immunogenic cell death (ICD) links tumor cell killing to antitumor immunity; however, cisplatin (CDDP), widely used in OC, is an incomplete ICD inducer. We previously demonstrated that the HIV protease inhibitor nelfinavir (NFV) enhances CDDP induced OC cell death and promotes a lytic, pyroptosis associated phenotype. Here, we investigated whether NFV enhances the immunogenic consequences of CDDP treatment. RNA seq analysis of OC cells treated with CDDP, NFV, or their combination revealed enrichment of interferon (IFN) associated, cytoplasmic DNA sensing, inflammatory chemokine, and antigen presentation pathways following NFV containing treatments. NFV alone and CDDP plus NFV reduced mature Lamin A abundance and increased extranuclear double stranded DNA accumulation. Cytosolic fractionation and droplet digital PCR demonstrated increased cytosolic TP53 DNA, particularly following combined treatment. CDDP plus NFV increased STING and TBK1 phosphorylation, supporting engagement of the cGAS STING TBK1 signaling pathway. The combination enhanced release of inflammatory and ICD associated mediators, including HMGB1, IL18, and IFNbeta. Importantly, vaccination with CDDP plus NFV-treated murine ID8 OC cells protected immunocompetent female mice against subsequent live ID8 cell challenge, reducing tumor incidence and burden. In contrast, ID8 cells killed by freeze thaw-induced accidental necrosis provided no comparable protection. Collectively, these findings indicate that NFV enhances the immunogenic consequences of CDDP induced OC cell death, potentially involving cytoplasmic DNA accumulation and STING TBK1 signaling, and promotes protective antitumor immunity in vivo. These results support further investigation of NFV as a repurposed partner for Pt based chemotherapy and its potential combination with immunotherapy in OC.

bioRxiv (Cold Spring Harbor Laboratory)
McGill University (CA), University of Chittagong (BD)
McGill University, Ovarian Cancer Canada
Good health and well-being
Ovarian cancer diagnosis and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon